Science
All studies and evidence
A complete overview of the human studies, reviews and clinical evidence behind the 7 pillars of Healthy7. Explore how each ingredient and benefit is supported by scientific research.
| # | Ingredient / Topic | Study title | Year | Participants | Study type | Findings | Source |
|---|---|---|---|---|---|---|---|
| 1 | Curcuma / curcumine | Curcumine - lipiden bij prediabetes/type 2 diabetes | 2026 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 2 | Curcuma / curcumine | Type 2 diabetes + obesitas - curcumine, inflammatie en antioxidatieve capaciteit | 2026 | 114 | RCT | Positive | PubMed(opens in a new tab) |
| 3 | Curcuma / curcumine | Prediabetes - curcumine + piperine en metabole markers | 2026 | 68 | RCT | Positive | PubMed(opens in a new tab) |
| 4 | Curcuma / curcumine | Curcumine/turmeric - benigne prostaathyperplasie en metabole/inflammatoire uitkomsten | 2026 | 697 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 5 | Curcuma / curcumine | Curcumine - ALT/AST bij NAFLD | 2025 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 6 | Curcuma / curcumine | Inspanning - Theracurmin en oxidatieve-stressmarkers | 2025 | 71 | RCT | Positive | PubMed(opens in a new tab) |
| 7 | Curcuma / curcumine | Inspanning - hydrolyzed curcumin en herstel/oxidatieve stress | 2025 | 34 | RCT | Positive | PubMed(opens in a new tab) |
| 8 | Curcuma / curcumine | Colitis ulcerosa - nano-curcumine en ziekteactiviteit/inflammatie | 2025 | 43 | RCT | Positive | PubMed(opens in a new tab) |
| 9 | Curcuma / curcumine | NAFLD - nano-curcumine en leverfibrose/steatose | 2025 | 55 | RCT | Positive | PubMed(opens in a new tab) |
| 10 | Curcuma / curcumine | Curcumine - orale submukeuze fibrose | 2024 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 11 | Curcuma / curcumine | Curcumine - leverenzymen bij NAFLD met GRADE-beoordeling | 2024 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 12 | Curcuma / curcumine | Peritoneale dialyse - curcumine en oxidatieve/inflammatoire markers | 2024 | 48 | RCT | Positive | PubMed(opens in a new tab) |
| 13 | Curcuma / curcumine | Curcumine - inflammatie, oxidatieve stress en endotheliale functie | 2024 | - | Meta-analyse van meta-analyses | Positive | PubMed(opens in a new tab) |
| 14 | Curcuma / curcumine | Curcumine - NAFLD en leverenzymen/metabole uitkomsten | 2024 | 835 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 15 | Curcuma / curcumine | Brede curcumine-evidence - meta-analyse van 103 RCT's en 42 uitkomsten | 2024 | 7.216 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 16 | Curcuma / curcumine | Curcumine - colitis ulcerosa en inflammatoire ziekteactiviteit | 2024 | 482 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 17 | Curcuma / curcumine | Curcumine - inflammatoire biomarkers (CRP, IL-6, TNF-α) | 2023 | 5.870 | Umbrella meta-analyse | Positive | PubMed(opens in a new tab) |
| 18 | Curcuma / curcumine | Hepatische steatose - curcumine + piperine en lever-/metabole markers | 2023 | 60 | RCT | Positive | PubMed(opens in a new tab) |
| 19 | Curcuma / curcumine | Curcumine - inflammatoire en oxidatieve-stressmarkers in 66 RCT's | 2023 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 20 | Curcuma / curcumine | Curcumine - lichaamsgewicht en adipositas | 2023 | - | Umbrella review/meta-analyse | Positive | PubMed(opens in a new tab) |
| 21 | Curcuma / curcumine | Post-COVID/vaccinatie - curcumine en inflammatoire markers | 2023 | 31 | RCT | Positive | PubMed(opens in a new tab) |
| 22 | Curcuma / curcumine | Curcumine - leverfunctie en leverenzymen in humane RCT's | 2023 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 23 | Curcuma / curcumine | NAFLD - curcumine en antropometrie, steatose en fibrose | 2023 | - | RCT | Positive | PubMed(opens in a new tab) |
| 24 | Curcuma / curcumine | Actieve colitis ulcerosa - Curcumin-QingDai en klinische respons | 2023 | 42 | RCT + pilot | Positive | PubMed(opens in a new tab) |
| 25 | Curcuma / curcumine | Curcumine - bloeddruk en cardiometabole uitkomsten | 2023 | 1.377 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 26 | Curcuma / curcumine | Reumatoïde artritis - curcumine en ziekteactiviteit/inflammatoire markers | 2023 | - | RCT | Positive | PubMed(opens in a new tab) |
| 27 | Curcuma / curcumine | Curcumine - CRP/hs-CRP als marker van systemische inflammatie | 2022 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 28 | Curcuma / curcumine | NAFLD - curcumine + piperine en lever/metabole uitkomsten | 2022 | 79 | RCT | Positive | PubMed(opens in a new tab) |
| 29 | Curcuma / curcumine | Chemotherapie - curcumine en behandelingsgerelateerde toxiciteit/oxidatieve processen | 2022 | 80 | RCT | Positive | PubMed(opens in a new tab) |
| 30 | Curcuma / curcumine | Knie-artrose - curcumine-extract en pijn/inflammatoire uitkomsten | 2022 | 101 | RCT | Positive | PubMed(opens in a new tab) |
| 31 | Curcuma / curcumine | COVID-19 - nano-curcumine en inflammatoire biomarkers | 2022 | 60 | RCT | Positive | PubMed(opens in a new tab) |
| 32 | Curcuma / curcumine | Migraine - curcumine en inflammatoire biomarkers | 2022 | - | RCT | Positive | PubMed(opens in a new tab) |
| 33 | Curcuma / curcumine | Curcumine - metabole biomarkers bij NAFLD | 2022 | - | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 34 | Curcuma / curcumine | Hemodialyse - curcumine en inflammatoire/oxidatieve markers | 2022 | 28 | RCT / secundaire analyse | Positive | PubMed(opens in a new tab) |
| 35 | Curcuma / curcumine | NAFLD - turmeric en lever-/metabole parameters | 2022 | 46 | RCT | Positive | PubMed(opens in a new tab) |
| 36 | Curcuma / curcumine | Curcumine - NAFLD, levervet en leverenzymen | 2022 | 1.028 | Systematische review + meta-analyse | Positive | PubMed(opens in a new tab) |
| 37 | Curcuma / curcumine | Curcumine - lipidenprofiel en cardiometabole markers | 2022 | - | Umbrella meta-analyse | Positive | PubMed(opens in a new tab) |
| 38 | Curcuma / curcumine | Metabool syndroom - curcumine/CoQ10 en cardiometabole markers | 2022 | 88 | 2×2 RCT | Positive | PubMed(opens in a new tab) |
| 39 | Curcuma / curcumine | Hemodialyse - turmeric ± piperine en oxidatieve stress | 2022 | - | RCT | Positive | PubMed(opens in a new tab) |
| 40 | Curcuma / curcumine | Coronaire angioplastie - nano-curcumine en inflammatoire/oxidatieve markers | 2021 | 90 | RCT | Positive | PubMed(opens in a new tab) |
1
PositiveCurcumine - lipiden bij prediabetes/type 2 diabetes
- Ingredient
- Curcuma / curcumine
- Year
- 2026
- Participants
- -
- Study type
- Systematische review + meta-analyse
2
PositiveType 2 diabetes + obesitas - curcumine, inflammatie en antioxidatieve capaciteit
- Ingredient
- Curcuma / curcumine
- Year
- 2026
- Participants
- 114
- Study type
- RCT
3
PositivePrediabetes - curcumine + piperine en metabole markers
- Ingredient
- Curcuma / curcumine
- Year
- 2026
- Participants
- 68
- Study type
- RCT
4
PositiveCurcumine/turmeric - benigne prostaathyperplasie en metabole/inflammatoire uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2026
- Participants
- 697
- Study type
- Systematische review + meta-analyse
5
PositiveCurcumine - ALT/AST bij NAFLD
- Ingredient
- Curcuma / curcumine
- Year
- 2025
- Participants
- -
- Study type
- Systematische review + meta-analyse
6
PositiveInspanning - Theracurmin en oxidatieve-stressmarkers
- Ingredient
- Curcuma / curcumine
- Year
- 2025
- Participants
- 71
- Study type
- RCT
7
PositiveInspanning - hydrolyzed curcumin en herstel/oxidatieve stress
- Ingredient
- Curcuma / curcumine
- Year
- 2025
- Participants
- 34
- Study type
- RCT
8
PositiveColitis ulcerosa - nano-curcumine en ziekteactiviteit/inflammatie
- Ingredient
- Curcuma / curcumine
- Year
- 2025
- Participants
- 43
- Study type
- RCT
9
PositiveNAFLD - nano-curcumine en leverfibrose/steatose
- Ingredient
- Curcuma / curcumine
- Year
- 2025
- Participants
- 55
- Study type
- RCT
10
PositiveCurcumine - orale submukeuze fibrose
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- -
- Study type
- Systematische review + meta-analyse
11
PositiveCurcumine - leverenzymen bij NAFLD met GRADE-beoordeling
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- -
- Study type
- Systematische review + meta-analyse
12
PositivePeritoneale dialyse - curcumine en oxidatieve/inflammatoire markers
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- 48
- Study type
- RCT
13
PositiveCurcumine - inflammatie, oxidatieve stress en endotheliale functie
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- -
- Study type
- Meta-analyse van meta-analyses
14
PositiveCurcumine - NAFLD en leverenzymen/metabole uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- 835
- Study type
- Systematische review + meta-analyse
15
PositiveBrede curcumine-evidence - meta-analyse van 103 RCT's en 42 uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- 7.216
- Study type
- Systematische review + meta-analyse
16
PositiveCurcumine - colitis ulcerosa en inflammatoire ziekteactiviteit
- Ingredient
- Curcuma / curcumine
- Year
- 2024
- Participants
- 482
- Study type
- Systematische review + meta-analyse
17
PositiveCurcumine - inflammatoire biomarkers (CRP, IL-6, TNF-α)
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- 5.870
- Study type
- Umbrella meta-analyse
18
PositiveHepatische steatose - curcumine + piperine en lever-/metabole markers
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- 60
- Study type
- RCT
19
PositiveCurcumine - inflammatoire en oxidatieve-stressmarkers in 66 RCT's
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- -
- Study type
- Systematische review + meta-analyse
20
PositiveCurcumine - lichaamsgewicht en adipositas
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- -
- Study type
- Umbrella review/meta-analyse
21
PositivePost-COVID/vaccinatie - curcumine en inflammatoire markers
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- 31
- Study type
- RCT
22
PositiveCurcumine - leverfunctie en leverenzymen in humane RCT's
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- -
- Study type
- Systematische review + meta-analyse
23
PositiveNAFLD - curcumine en antropometrie, steatose en fibrose
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- -
- Study type
- RCT
24
PositiveActieve colitis ulcerosa - Curcumin-QingDai en klinische respons
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- 42
- Study type
- RCT + pilot
25
PositiveCurcumine - bloeddruk en cardiometabole uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- 1.377
- Study type
- Systematische review + meta-analyse
26
PositiveReumatoïde artritis - curcumine en ziekteactiviteit/inflammatoire markers
- Ingredient
- Curcuma / curcumine
- Year
- 2023
- Participants
- -
- Study type
- RCT
27
PositiveCurcumine - CRP/hs-CRP als marker van systemische inflammatie
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- -
- Study type
- Systematische review + meta-analyse
28
PositiveNAFLD - curcumine + piperine en lever/metabole uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 79
- Study type
- RCT
29
PositiveChemotherapie - curcumine en behandelingsgerelateerde toxiciteit/oxidatieve processen
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 80
- Study type
- RCT
30
PositiveKnie-artrose - curcumine-extract en pijn/inflammatoire uitkomsten
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 101
- Study type
- RCT
31
PositiveCOVID-19 - nano-curcumine en inflammatoire biomarkers
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 60
- Study type
- RCT
32
PositiveMigraine - curcumine en inflammatoire biomarkers
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- -
- Study type
- RCT
33
PositiveCurcumine - metabole biomarkers bij NAFLD
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- -
- Study type
- Systematische review + meta-analyse
34
PositiveHemodialyse - curcumine en inflammatoire/oxidatieve markers
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 28
- Study type
- RCT / secundaire analyse
35
PositiveNAFLD - turmeric en lever-/metabole parameters
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 46
- Study type
- RCT
36
PositiveCurcumine - NAFLD, levervet en leverenzymen
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 1.028
- Study type
- Systematische review + meta-analyse
37
PositiveCurcumine - lipidenprofiel en cardiometabole markers
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- -
- Study type
- Umbrella meta-analyse
38
PositiveMetabool syndroom - curcumine/CoQ10 en cardiometabole markers
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- 88
- Study type
- 2×2 RCT
39
PositiveHemodialyse - turmeric ± piperine en oxidatieve stress
- Ingredient
- Curcuma / curcumine
- Year
- 2022
- Participants
- -
- Study type
- RCT
40
PositiveCoronaire angioplastie - nano-curcumine en inflammatoire/oxidatieve markers
- Ingredient
- Curcuma / curcumine
- Year
- 2021
- Participants
- 90
- Study type
- RCT
Showing 40 of 283 studies